Calibr at Scripps Research Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Calibr at Scripps Research's estimated annual revenue is currently $27M per year.(i)
  • Calibr at Scripps Research's estimated revenue per employee is $155,000

Employee Data

  • Calibr at Scripps Research has 174 Employees.(i)
  • Calibr at Scripps Research grew their employee count by 4% last year.

Calibr at Scripps Research's People

NameTitleEmail/Phone
1
VP Nonclinical DevelopmentReveal Email/Phone
2
VP, BiologicsReveal Email/Phone
3
Associate DirectorReveal Email/Phone
4
Associate DirectorReveal Email/Phone
5
Director, Metabolic DiseasesReveal Email/Phone
6
Associate DirectorReveal Email/Phone
7
Associate Director, PharmacologyReveal Email/Phone
8
Associate Director (Medicinal Chemistry)Reveal Email/Phone
9
Associate Director, ChemistryReveal Email/Phone
10
Associate Director Immuno OncologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Calibr at Scripps Research?

The California Institute for Biomedical Research (Calibr) is an independent, not-for-profit organization established to accelerate the translation of basic biomedical research to innovative new medicines. Scientists at Calibr work together with investigators at other academic institutions and non-profit foundations to advance exciting research discoveries and technologies to new medicines for the treatment of human disease. Calibr?s research interests span a large range of human diseases, including cancer, autoimmunity and inflammatory diseases, metabolic and cardiovascular diseases, infectious and neglected diseases, as well as age-related and degenerative diseases. Calibr?s research space includes a newly renovated 35,000 square foot facility in La Jolla, CA, which houses over 110 interdisciplinary scientists and staff with state-of-the-art instrumentation. This infrastructure, combined with Calibr?s drug discovery expertise, enables projects rooted in novel therapeutic mechanisms to progress from the laboratory through preclinical development and ultimately to the clinic through commercial, federal or foundation partnerships.

keywords:N/A

N/A

Total Funding

174

Number of Employees

$27M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Calibr at Scripps Research News

2022-04-17 - Tech Transfer Roundup: Lysogene Elects Option On Gene ...

The initial SARS-CoV-2 research program at Calibr, the Scripps' drug discovery and development division, was supported by funding from the...

2022-04-06 - Newly identified cell type could be the key to restoring ...

image: Scientists at Scripps Research and the National Institute of Dental and ... Our drug discovery and development division, Calibr,...

2022-03-22 - AbbVie and Scripps Research Announce Collaboration to ...

The initial SARS-CoV-2 research program at Calibr, the drug discovery and development division of Scripps Research, was supported by funding...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M17412%N/A
#2
$27.8M174-3%N/A
#3
$34.5M17431%N/A
#4
$27.9M17510%N/A
#5
$40.4M175N/AN/A